Pune: Serum Institute To Continue Corona Vaccine Trial, AstraZeneca Halts in UK
London/Pune, September 9, 2020: London-based pharma company AstraZeneca, which is developing the Corona vaccine in collaboration with Oxford University, had to stop clinical trials. This decision had to be taken because a person involved in the trial got ill. The company gave this information on Tuesday and described it as routine action. They also said that the severity of the disease in the patient is not yet known.
Commenting on the recent reports on AstraZeneca halting the trials in the UK, Pune-based Serum Institute of India (SII), said, “We can’t comment much on the UK trials, but they have been paused for further review and they hope to restart soon. As far as Indian trials are concerned, it is continuing and we have faced no issues at all.”
‘There should not be much delay in trial, we are taking care of it’
AstraZeneca said, “If there is an unexplained illness in the middle of a trial, then the trial is stopped. It sometimes happens in big trials, but we must review it. Working on it so that the timeline of the trial does not have much impact. “
9 companies are currently in phase three trials.
AstraZeneca started the registration of 30,000 volunteers for the phase three clinical trial from 31 August. AstraZeneca is one of the nine companies whose vaccine trials are in the third or last phase.
